Delivery Order SPE2DR25D2214-SPE2DR26FV7M6
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,097.78 for Ondansetron ODT 4 mg tablets (30-count supply) on November 28, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. Performance is scheduled for completion by December 1, 2025, and work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,962.99 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packaging) on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen...
- The Defense Logistics Agency awarded a $15,452.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Ondansetron ODT 8 mg tablets (30-count units), with an ultimate completion date of January 8, 2026. This non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Ondansetron ODT 4 mg tablets (30-count packaging) with a ceiling value of $14,532.25. This firm fixed-price delivery order, which carries an ultimate completion date of January 9, 2026, was competitively awarded with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $12,033.07 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count package). This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of December 22, 2025. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $34,947.77 delivery order to AmerisourceBergen Drug Corp (via parent company Cencora, Inc.) on January 6, 2026, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30. The contract is a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award was made on a fully competitive, non-set-aside basis, demonstrating the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $23,772.45 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This competitively awarded, firm fixed-price delivery order was issued on November 28, 2025, with an ultimate completion date of December 1, 2025. The contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units, with a ceiling value of $8,606.93. The delivery order, issued on October 14, 2025, with an ultimate completion date of October 15, 2025, represents a non-competitive award under the company's existing contract vehicle with DLA. The place of performance is located at AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a contract ceiling value of $15,399.64. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The contract has an ultimate completion date of January 6, 2026, and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $5,724.72 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This firm fixed-price delivery order, which is set to be completed by January 7, 2026, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete on a full...
- SPE2DR25D2214Indefinite Delivery Contract
- SPE2DR25D2214-SPE2DR26FV7M6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,663.17 to Amerisourcebergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count package). The award, issued on January 8, 2026, is structured as a firm fixed-price contract with an ultimate completion date of January 9, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This contract was not designated as a set-aside and was competitively awarded, reflecting Amerisourcebergen's capability to meet federal pharmaceutical procurement requirements in open competition. This delivery order is issued under Amerisourcebergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. Ondansetron is an antiemetic medication commonly used in military and federal healthcare settings to manage nausea and vomiting, making this routine delivery order a component of the DLA's broader medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/7/26 |